Dr. ir. B.J. (Berend Jan) Bosch

Dr. ir. B.J. (Berend Jan) Bosch

Associate Professor
Infectious Diseases & Immunology
+31 30 253 4195
b.j.bosch@uu.nl

Activities

2019

serological screening for coronaviruses in catsBosch, B. J. (Presenter)
28 Apr 20191 May 2019
, European Congress of Virology 2019

2016

Het porcine epidemische diarree virusBosch, B. J. (Invited speaker)
10 Apr 2016
, Voorjaarsdagen 2015

2015

Porcine epidemic diarrhea virus: an emerging problemBosch, B. J. (Invited speaker)
19 Nov 2015
, Veterinary Science Day
Receptor and membrane-fusion activation determinants for a trypsin-dependent enteric porcine coronavirusBosch, B. J. (Invited speaker)
19 May 2015
, Eighth International Virus Assembly Symposium
'Witte Huis' lectureBosch, B. J. (Invited speaker)
17 Apr 2015
Emerging pathogenic coronaviruses: How do they enter the host-cell?Bosch, B. J. (Invited speaker)
16 Jan 2015

2013

Dipeptidyl peptidase 4: Entry portal for the emerging MERS-coronavirusBosch, B. J. (Invited speaker)
13 Sept 2013
, ECV2013 (Lyon, France)
Identification of the receptor for the emerging MERS-coronavirusBosch, B. J. (Invited speaker)
23 May 2013
, Seminar CVI
Dipeptidyl Peptidase 4 is a Functional Receptor for the Emerging Human Coronavirus-EMCBosch, B. J. (Invited speaker)
30 Apr 2013
, Keystone Symposium on Positive Strand RNA Viruses (Boston, Massachusetts, USA)
Entry of coronaviruses into the host cellBosch, B. J. (Invited speaker)
15 Apr 2013
, Seminar
Production of soluble, multimeric, bioactive viral glycoprotein and receptor discovery for a novel and emerging human coronavirusBosch, B. J. (Invited speaker)
2013
, Seminar Bedrijf ProteinSciences

2012

Non-spreading Rift Valley fever virus particles: effective as experimental vaccine and valuable to study virus entryBosch, B. J. (Invited speaker)
21 Jul 2012
, 31st Annual Meeting ASV
Non-spreading Rift Valley fever virus particles: effective as experimental vaccine and valuable to study virus entryBosch, B. J. (Invited speaker)
26 Jun 2012
, Meeting
Non-spreading Rift Valley fever virus particles: effective as experimental vaccine and valuable to study virus entryBosch, B. J. (Invited speaker)
17 May 2012
, Seventh International Virus Assembly Symposium (Menorca, Spain)
Cell Entry of Rift Valley fever virusBosch, B. J. (Invited speaker)
12 May 2012
, Network meeting ‘Virus Entry’ ITN-EU

2011

Porcine epidemic diarrhea virus: Manipulation of the viral genomeBosch, B. J. (Invited speaker)
14 Dec 2011
, Seminar at Veterinary Medicine Shanghai Academy of Agricultural Sciences
Biomembrane Dynamics: From molecules to CellsBosch, B. J. (Invited speaker)
20 Jun 201130 Jun 2011

2010

A novel, effective and versatile vaccine approach against influenza: multimeric recombinant HA and NA glycoproteinsBosch, B. J. (Invited speaker)
24 Oct 2010
, 4th International Symposium on Emerging Viral Diseases (Wuhan, China)
RVFV subunit vaccines confer complete protection against a lethal challengeBosch, B. J. (Invited speaker)
7 Jun 201010 Jun 2010
, 4th Annual Epizone Meeting

2009

Interventions against WNV, RVFV and CCHFV: Where are we?Bosch, B. J. (Invited speaker)
18 Nov 200920 Nov 2009
, ARBOZOONET FP7 SYMPOSIUM

2007

Dependence of SARS coronavirus cell entry on cellular proteasesBosch, B. J. (Invited speaker)
11 May 2007
, Meeting

2004

SARS-CoV infection inhibition using spike protein heptad repeat derived peptidesBosch, B. J. (Invited speaker)
27 May 2004
, 7th international symposium on positive strand RNA viruses (San Francisco)
SARS-CoV infection inhibition using spike protein heptad repeat derived peptidesBosch, B. J. (Invited speaker)
8 May 2004
, International Conference on SARS one year after the (first) outbreak
Study group Lipids and Biomembranes of NWO-CW, Lunteren, The NetherlandsBosch, B. J. (Invited speaker)
8 Mar 2004
, Study Group Lipids and Biomembranes of NWO-CW (Lunteren)
ON THE MEMBRANE FUSION MECHANISM USED BY CORONAVIRUSES TO ENTER THEIR TARGET CELLSBosch, B. J. (Invited speaker)
8 Mar 2004
, Study group Lipids and Biomembranes of NWO-CW